Published in Diabetes on September 01, 1989
Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome | NCT00679679
Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome | NCT01588873
Effects of Fasting Mimicking Diet (FMD) in Women With Polycystic Ovary Syndrome (PCOS) | NCT05196568
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab (2010) 2.58
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med (2010) 2.21
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.70
Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets. Diabetes (2013) 1.64
Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril (2007) 1.55
Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health (2008) 1.47
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest (1995) 1.32
The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab (2008) 1.18
Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.17
Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. J Clin Endocrinol Metab (2009) 1.14
Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J Clin Invest (1998) 1.12
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
Ovarian steroids: the good, the bad, and the signals that raise them. Cell Cycle (2006) 1.05
Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab (2013) 1.04
Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.03
Oocyte maturation: the coming of age of a germ cell. Semin Reprod Med (2005) 1.02
Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. J Clin Endocrinol Metab (2011) 1.01
Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res (2010) 1.01
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism (2007) 1.00
Insulin resistance and hyperinsulinemia: you can't have one without the other. Diabetes Care (2008) 0.99
Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab (2013) 0.99
Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol (2007) 0.99
Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 0.97
Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 0.97
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet (2010) 0.96
Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm (2010) 0.96
Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause (2007) 0.95
Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod (2008) 0.95
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab (2008) 0.95
Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Med Sci Sports Exerc (2009) 0.94
Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med (2012) 0.94
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol (2005) 0.93
Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord (2010) 0.93
Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Hum Reprod (2011) 0.92
The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS One (2011) 0.91
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism (2008) 0.91
Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One (2010) 0.91
The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS. J Hum Reprod Sci (2009) 0.90
Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One (2014) 0.90
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity. J Clin Endocrinol Metab (2012) 0.90
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). Int J Pediatr Endocrinol (2011) 0.90
Polycystic Ovary Syndrome and Obstructive Sleep Apnea. Sleep Med Clin (2008) 0.90
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab (2016) 0.90
Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol (2012) 0.89
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab (2012) 0.89
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril (2008) 0.89
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab (2008) 0.89
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. Fertil Steril (2007) 0.88
Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.88
Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int J Obes (Lond) (2007) 0.87
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity. PLoS Genet (2015) 0.87
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes (2012) 0.87
Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J Clin Endocrinol Metab (2014) 0.87
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol (2016) 0.87
Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. Hum Reprod (2012) 0.86
Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women. Korean J Fam Med (2016) 0.85
Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab (2013) 0.85
Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol (2012) 0.85
Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation. Metabolism (2008) 0.85
Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol (2014) 0.84
Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci (2008) 0.84
Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia (2007) 0.84
Genetics of polycystic ovary syndrome. Hippokratia (2009) 0.84
Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health (Larchmt) (2010) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys. Am J Physiol Endocrinol Metab (2014) 0.83
Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index. PLoS One (2014) 0.83
A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab (2014) 0.83
Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean J Intern Med (2009) 0.82
Should all women with PCOS be treated for insulin resistance? Fertil Steril (2012) 0.82
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2011) 0.82
Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population. Indian J Clin Biochem (2012) 0.82
The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol (2003) 0.82
Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab (2014) 0.82
Screening for diabetes in pregnancy. J R Soc Med (2001) 0.81
Genetics of polycystic ovary syndrome. Semin Reprod Med (2014) 0.81
Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. Bosn J Basic Med Sci (2013) 0.81
Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women. Int J Endocrinol (2015) 0.81
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol (2008) 0.80
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells. Endocrinology (2009) 0.80
Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know. Eur J Endocrinol (2013) 0.80
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome. CMAJ (2007) 0.80
The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. J Assist Reprod Genet (2011) 0.80
The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Res Notes (2012) 0.80
Expression and clinical significance of the HIF-1a/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome. J Mol Histol (2015) 0.79
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin. Endocr Pract (2012) 0.79
Simple modeling allows prediction of steady-state glucose disposal rate from early data in hyperinsulinemic glucose clamps. Am J Physiol Endocrinol Metab (2009) 0.79
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol (2015) 0.79
Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids. Am J Physiol Endocrinol Metab (2015) 0.79
Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab (2015) 0.79
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia (2017) 0.78
Partial purification of a serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1976) 2.42
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (1998) 1.97
Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med (2000) 1.77
Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes (1992) 1.54
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med (2000) 1.51
Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med (1996) 1.51
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab (1987) 1.50
Estimation of human body composition by electrical impedance methods: a comparative study. J Appl Physiol (1985) (1985) 1.24
Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord (2003) 1.20
Thermic effect of food at rest, during exercise, and after exercise in lean and obese men of similar body weight. J Clin Invest (1985) 1.11
Thermic effects of food and exercise in lean and obese women. Metabolism (1983) 1.10
Coexistence of Prader-Willi syndrome, congenital ectropion uveae with glaucoma, and factor XI deficiency. JAMA (1986) 1.06
Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab (2001) 1.05
Thermic effect of food during graded exercise in normal weight and obese men. Am J Clin Nutr (1984) 1.04
Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab (1986) 1.03
Clinical applications of a gas chromatographic method for the combined determination of testosterone and epitestosterone glucuronide in urine. J Clin Endocrinol Metab (1965) 0.98
Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab (1990) 0.96
Comparison of indirect calorimetric measurements of resting energy expenditure with a ventilated hood, face mask, and mouthpiece. Am J Clin Nutr (1987) 0.93
Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest (1989) 0.89
American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract (2003) 0.89
Plasma lactate and ventilation thresholds in trained and untrained cyclists. J Appl Physiol (1985) (1986) 0.88
Soluble factors guide gonadotropin-releasing hormone axonal targeting to the median eminence. Endocrinology (2000) 0.87
The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab (1988) 0.87
Metabolic and hemodynamic responses to exercise in subcutaneous adipose tissue and skeletal muscle. Int J Sports Med (2002) 0.84
Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab (1991) 0.84
Polycystic ovarian disease: US features in 104 patients. Radiology (1987) 0.83
Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease. Fertil Steril (1979) 0.83
Continuous gonadotropin-releasing hormone infusion stimulates dramatic gonadal development in hypogonadal female mice. Biol Reprod (1994) 0.83
Cardiorespiratory responses to ballet exercise and the VO2max of elite ballet dancers. Med Sci Sports Exerc (1982) 0.82
Galactorrhea in primary hypothyroidism: report of two cases and review of the literature. Mt Sinai J Med (1970) 0.82
Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells. J Natl Cancer Inst (1982) 0.82
Echocardiographic mitral valve prolapse in ballet dancers: a function of leanness. Am Heart J (1987) 0.80
Endocrine evaluation of forty female-to-male transsexuals: increased frequency of polycystic ovarian disease in female transsexualism. Arch Sex Behav (1986) 0.79
Nicotinamide adenine dinucleotide glycohydrolases from Ehrlich ascites tumor cell nuclei: isolation, partial purification, and properties. Biochemistry (1972) 0.79
Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med (1991) 0.79
Use of insulin-sensitizing agents in patients with polycystic ovary syndrome. Endocr Pract (2001) 0.78
Two-dimensional echocardiographic findings in patients on hemodialysis for more than six months. Am J Cardiol (1987) 0.78
Thermic effects of food and exercise in lean and obese men of similar lean body mass. Am J Physiol (1987) 0.78
pH-dependent inactivation of nicotinamide--adenine dinucleotide glycohydrolase by its substrate, oxidized nicotinamide--adenine dinucleotide. Biochemistry (1971) 0.78
Anorchia. A variety of the "empty scrotum". JAMA (1971) 0.78
Relationship of the nicotinamide adenine dinucleotide glycohydrolase activity to nicotinamide adenine dinucleotide content and rate of proliferation of Ehrlich ascites tumor cells. Cancer Res (1967) 0.77
Energy depot replenishment in rats during refeeding after fasting: effect of exercise. Am J Clin Nutr (1984) 0.77
Androgen receptor immunoreactivity in specific neural regions in normal and hypogonadal male mice: effect of androgens. Brain Res (1999) 0.77
Hyperthyroidism in patients treated with lithium: report of nine cases. Mt Sinai J Med (1992) 0.77
Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients. Neurosurgery (1980) 0.77
Corynebacterium parvum: effects on the biochemistry of mouse serum and liver. J Natl Cancer Inst (1979) 0.77
Inactivation of nicotinamide-adenine dinucleotide glycohydrolase from livers of different mammalian species by nicotinamide-adenine dinucleotide. Biochemistry (1971) 0.77
Histopathology of the breasts of 12 women receiving long-term exogenous androgen therapy. Mt Sinai J Med (1988) 0.76
Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness. Fertil Steril (1985) 0.76
Validity of a new portable indirect calorimeter: the AeroSport TEEM 100. Eur J Appl Physiol Occup Physiol (1995) 0.76
Cerebellar tumor causing hypertensive crisis and simulating pheochromocytoma and Cushing's syndrome. Mt Sinai J Med (1989) 0.76
Myotonic dystrophy presenting as male infertility: a case report. Int J Fertil (1987) 0.76
A relation between pyridine nucleotide-dependent dehydrogenase activity and nicotinamide adenine dinucleotide glycohydrolase in Ehrlich ascites tumor cells. Cancer Res (1970) 0.75
Postpartum amenorrhea, diabetes insipidus and galactorrhea. Report of a case and review of the literature. Am J Med (1974) 0.75
Effects of new 9,11-dihalogenated corticosteroids in various types of alopecia. II. Pituitary-adrenal responsiveness in patients treated with 16 alpha-methyl-dichlorisone alcohol. J Mt Sinai Hosp N Y (1967) 0.75
Dissociation of serum prolactin response to sequential thyrotropin-releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome. Fertil Steril (1984) 0.75
Comparison in man of total body electrical conductivity and lean body mass derived from body density: validation of a new body composition method. Metabolism (1983) 0.75
Exercise, resting metabolic rate, and thermogenesis. Diabetes Metab Rev (1986) 0.75
Effects of androgens on the ovary. Fertil Steril (1986) 0.75
Gas chromatographic determination of urinary testosterone and epitestosterone glucuronide. Mt Sinai J Med (1971) 0.75
Increased oestradiol in diazepam related gynaecomastia. Lancet (1981) 0.75
A role for nicotinamide adenine dinucleotide glycohydrolase in the control of glyceraldehyde-3-phosphate dehydrogenase activity. Cancer Res (1969) 0.75
Hypothesis: aberrant puberty and the Stein-Leventhal syndrome. Int J Fertil (1984) 0.75
A protein fraction (NHG) from serum of normal humans which is cytotoxic for HeLa cells in culture. Cancer Lett (1981) 0.75
The effect of probenecid on serum lipids: a study of diabetics and non-diabetics without gout. J Mt Sinai Hosp N Y (1967) 0.75
Pituitary tumors and polycystic ovarian disease. Obstet Gynecol (1983) 0.75
Müllerian remnants in complete androgen insensitivity syndrome. Int J Fertil (1992) 0.75
On the expression of H-Y antigen in transsexuals. Arch Sex Behav (1986) 0.75
[Physical activity exhibits differences in the action of fat metabolism in men and women--results of a microdialysis study]. Forsch Komplementarmed (1999) 0.75
Measurement of urinary testosterone and epitestosterone glucuronide as a test of gonadal reserve. Fertil Steril (1967) 0.75
Endocrine management of transsexual. Hormonal profiles of serum prolactin, testosterone, and estradiol. N Y State J Med (1980) 0.75
The aberrant puberty hypothesis of polycystic ovarian disease: a review. Mt Sinai J Med (1986) 0.75
Effects of new 9,11-dihalogenated corticosteroids in various types of alopecia. I. Clinical studies in 32 patients. J Mt Sinai Hosp N Y (1967) 0.75
Left ventricular hypertrophy in athletes: an exercise-echocardiographic study. Med Sci Sports Exerc (1985) 0.75
Refractory biventricular heart failure in secondary hemochromatosis. Am J Med Sci (1985) 0.75
Blepharoptosis in diabetes mellitus. J Clin Endocrinol Metab (1965) 0.75
A rapid method for the isolation of nuclei from Ehrlich ascites tumor cells. Cancer Res (1970) 0.75
Treatment of normogonadotropic oligospermia with large doses of chorionic gonadotropin. Fertil Steril (1969) 0.75
Gonadal reserve test in male hypogonadism. Fertil Steril (1970) 0.75
TOBEC methodology for body composition assessment: a cross-validation study. Am J Clin Nutr (1987) 0.75
Spermatozoa in seminal fluid of a patient with Klinefelter's syndrome. Fertil Steril (1967) 0.75
A case of bilateral dermoid cysts, insulin resistance, and polycystic ovarian disease: association of ovarian tumors with polycystic ovaries with review of the literature. Mt Sinai J Med (1983) 0.75
Testicular steroidogenic response to human chorionic gonadotropin of fifteen male transsexuals on chronic estrogen treatment. Metabolism (1984) 0.75
Thyroid nodules in the irradiated patient--an indication for total thyroidectomy. J Surg Oncol (1985) 0.75
Hyperparathyroidism with aberrant hyperplastic parathyroid located within thyroid adenoma. Mt Sinai J Med (1979) 0.75
Galactorrhea, amenorrhea, hyperprolactinemia and pseudotumor cerebri in a patient with primary empty sella syndrome: case report with review of the literature. Mt Sinai J Med (1983) 0.75
Multifollicular ovaries in weight-loss-related amenorrhoea. Lancet (1986) 0.75
Normal plasma gonadotropin response to gonadotropin-releasing hormone after diethylstilbestrol priming in transsexual women. J Clin Endocrinol Metab (1983) 0.75
Buccal androsterone therapy of hirsutism: a preliminary report. J Mt Sinai Hosp N Y (1968) 0.75
hCG treatment in oligoasthenospermia. Fertil Steril (1983) 0.75